KEGG pathways targeted by downregulated miRNAs |
Adherence junction (hsa04520) |
Biotin metabolism (hsa00780) |
Glycosphingolipid biosynthesis, lacto- and neolactoseries (hsa00601) |
Pancreatic secretion (hsa04972) |
Protein processing in endoplasmic reticulum (hsa04141) |
Ubiquitin mediated proteolysis (hsa04120) |
Rap1 signaling pathway (hsa04015) |
Thyroid hormone signaling pathway (hsa04919) |
ā |
KEGG pathways targeted by upregulated miRNAs |
Axon guidance (hsa04360) |
Mucin type O-glycan biosynthesis (hsa00512) |
Valine, leucine, and isoleucine biosynthesis (hsa00290) |
Circadian rhythm (hsa04710) |
ECM-receptor interaction (hsa04512) |
Gap junction (hsa04540) |
Focal adhesion (hsa04510) |
Estrogen signaling pathway (hsa04915) |
Hippo signaling pathway (hsa04390) |
FoxO signaling pathway (hsa04068) |
mTOR signaling pathway (hsa04150) |
Wnt signaling pathway (hsa04310) |
Signaling pathways regulating pluripotency of stem cells (hsa04550) |
TGF-beta signaling pathway (hsa04350) |
PI3K-Akt signaling pathway (hsa04151) |
Prion diseases (hsa05020) |
Viral carcinogenesis (hsa05203) |
Hepatitis B (hsa05161) |
Chronic myeloid leukemia (hsa05220) |
Glioma (hsa05214) |
Melanoma (hsa05218) |
Non-small cell lung cancer (hsa05223) |
Pancreatic cancer (hsa05212) |
Pathways in cancer (hsa05200) |
Prostate cancer (hsa05215) |
Proteoglycans in cancer (hsa05205) |
Renal cell carcinoma (hsa05211) |
Thyroid cancer (hsa05216) |
Transcriptional misregulation in cancer (hsa05202) |